De Meyer GR - Search Results

1

Evaluating the implementation fidelity of New Medicines Service for asthma patients in community pharmacies in Belgium.

Fraeyman J, Foulon V, Mehuys E, Boussery K, Saevels J, De Vriese C, Dalleur O, Housiaux M, Steurbaut S, Naegels M, De Meyer GR, De Loof H, Van Hal G, Van den Broucke S. Fraeyman J, et al. Among authors: de loof h, de vriese c, de meyer gr. Res Social Adm Pharm. 2017 Jan-Feb;13(1):98-108. doi: 10.1016/j.sapharm.2016.02.001. Epub 2016 Feb 12. Res Social Adm Pharm. 2017. PMID: 26975932

2

[Statins under fire: justified or not?].

Declerck E, De Loof H, De Meyer GR. Declerck E, et al. Among authors: de loof h, de meyer gr. J Pharm Belg. 2009 Dec;(4):119-30. J Pharm Belg. 2009. PMID: 20183988 Review. French.

3

[How to improve the collaboration between GP and community pharmacist? A survey in Antwerpen and Limburg].

Janssen S, De Loof H, De Meyer GR. Janssen S, et al. Among authors: de loof h, de meyer gr. J Pharm Belg. 2010 Dec;(4):118-29. J Pharm Belg. 2010. PMID: 21294318 French. No abstract available.

4

[Pharmaceutical care of heart failure: theory and clinical practice].

Gysen C, De Loof H, De Meyer G. Gysen C, et al. J Pharm Belg. 2011 Sep;(3):68-75. J Pharm Belg. 2011. PMID: 21995098 Review. French.

5

Potential impact of policy regulation and generic competition on sales of cholesterol lowering medication, antidepressants and acid blocking agents in Belgium.

Fraeyman J, Van Hal G, De Loof H, Remmen R, De Meyer GR, Beutels P. Fraeyman J, et al. Among authors: de loof h, de meyer gr. Acta Clin Belg. 2012 May-Jun;67(3):160-71. doi: 10.2143/ACB.67.3.2062650. Acta Clin Belg. 2012. PMID: 22897063

6

[Critical evaluation of interaction screening software available in pharmacies].

Schillemans S, De Loof H, De Meyer GR. Schillemans S, et al. Among authors: de loof h, de meyer gr. J Pharm Belg. 2012 Dec;(4):4-13. J Pharm Belg. 2012. PMID: 23350206 Review. French.

7

[Opinions and attitudes of Flemish pharmacists and general practitioners towards INN prescribing. A survery in Antwerp and East Flanders].

Fraeyman J, De Winter J, De Loof H, Van Hal G, Beutels P, Remmen R, De Meyer GR. Fraeyman J, et al. Among authors: de winter j, de loof h, de meyer gr. J Pharm Belg. 2013 Jun;(2):18-31. J Pharm Belg. 2013. PMID: 23798183 French.

8

mTOR inhibition: a promising strategy for stabilization of atherosclerotic plaques.

Martinet W, De Loof H, De Meyer GRY. Martinet W, et al. Atherosclerosis. 2014 Apr;233(2):601-607. doi: 10.1016/j.atherosclerosis.2014.01.040. Epub 2014 Jan 29. Atherosclerosis. 2014. PMID: 24534455 Review.

9

[Drug related problems in Belgian community pharmacies].

Huysmans K, De Wulf I, Foulon V, De Loof H, Steurbaut S, Boussery K, De Vriese C, Lacour V, Van Hees T, De Meyer GR. Huysmans K, et al. Among authors: de loof h, de vriese c, de meyer gr, de wulf i. J Pharm Belg. 2014 Mar;(1):4-15. J Pharm Belg. 2014. PMID: 24804389 French.

10

Medicine price awareness in chronic patients in Belgium.

Fraeyman J, Symons L, De Loof H, De Meyer GR, Remmen R, Beutels P, Van Hal G. Fraeyman J, et al. Among authors: de loof h, de meyer gr. Health Policy. 2015 Feb;119(2):217-23. doi: 10.1016/j.healthpol.2014.12.004. Epub 2014 Dec 8. Health Policy. 2015. PMID: 25533549

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

258 results

Search Page

Filters